Parmax Pharma Share Price
135.05+1.30 (+0.97%)
+310.24% past 1 Year
Corporate filings & documents
Announcements
Newspaper Publication for 32nd Annual general Meeting of the Company
1 week agoNewspaper Publication for 32nd Annual general Meeting of the Company
1 week agoAnnual Report of Financial Year 2025-26 along with Notice of Annual General Meeting
1 week agoAnnual Report of Financial Year 2025-26 along with Notice of Annual General Meeting
1 week agoNotice of Annual General Meeting of Company
1 week agoNotice of Annual General Meeting of Company
1 week agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dhiren Shah & PACs
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dhiren Shah & PACs
2 weeks agoAllotment of Equity Shares and Convertible warrants on a preferential basis
3 weeks agoAllotment of Equity Shares and Convertible warrants on a preferential basis
3 weeks agoIntimation of Reclassification of Promoters under Regulations 31A of SEBI (LODR) Regulations 2015
3 weeks agoIntimation of Reclassification of Promoters under Regulations 31A of SEBI (LODR) Regulations 2015
3 weeks agoFedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Post Offer Advertisement in accordance with Regulations 18(12) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 as amended with respect to the Open Offer for the attention of the Public Shareholders of Parmax Pharma Limited (Target Company).
4 weeks agoFedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Post Offer Advertisement in accordance with Regulations 18(12) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 as amended with respect to the Open Offer for the attention of the Public Shareholders of Parmax Pharma Limited (Target Company).
4 weeks agoReceipt of In Principle Approval
4 weeks agoReceipt of In Principle Approval
4 weeks agoNewspaper publication of extract of Financial results of quarter ended June 30 2026
1 month agoNewspaper publication of extract of Financial results of quarter ended June 30 2026
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Alkesh Mahasukhlal Gopani & Others
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Alkesh Mahasukhlal Gopani & Others
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dhiren Chandulal Shah Sunil Chinubhai Shah & PACs
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dhiren Chandulal Shah Sunil Chinubhai Shah & PACs
1 month agoAppointment of Mr. Dhiren Shah Mr. Sunil Shah as an Additional Directors and recommendation of Ms. Anjana Shah Ashish Shah as an Independent Directors subject to prior approval of shareholders and resignation of Ms. Salma Thobhani from the post of Non executive and Non Independent Director of the company
1 month agoAppointment of Mr. Dhiren Shah Mr. Sunil Shah as an Additional Directors and recommendation of Ms. Anjana Shah Ashish Shah as an Independent Directors subject to prior approval of shareholders and resignation of Ms. Salma Thobhani from the post of Non executive and Non Independent Director of the company
1 month agoResults for quarter ended June 30 2026
1 month agoResults for quarter ended June 30 2026
1 month agoOutcome of Board Meeting as per attached
1 month agoOutcome of Board Meeting as per attached
1 month agoThe Exchange has received the disclosure under Regulation 18(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sunil Shah & Others
1 month agoThe Exchange has received the disclosure under Regulation 18(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sunil Shah & Others
1 month agoParmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve quarterly financial results for quarter ended June 30 2026
1 month agoParmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve quarterly financial results for quarter ended June 30 2026
1 month agoFedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of newspaper publication of Offer Opening Pre-Offer Advertisement to the Public Shareholders of Parmax Pharma Ltd ("Target Company").
1 month agoFedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of newspaper publication of Offer Opening Pre-Offer Advertisement to the Public Shareholders of Parmax Pharma Ltd ("Target Company").
1 month agoFedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of newspaper publication of Recommendations of the Committee of Independent Directors (IDC) to the Public Shareholders of Parmax Pharma Ltd ("Target Company").
1 month agoFedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of newspaper publication of Recommendations of the Committee of Independent Directors (IDC) to the Public Shareholders of Parmax Pharma Ltd ("Target Company").
1 month agoFedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Public Shareholders of Parmax Pharma Ltd ("Target Company").
2 months agoFedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Public Shareholders of Parmax Pharma Ltd ("Target Company").
2 months agoCompliance Certificate for quarter ended June 30 2026
2 months agoCompliance Certificate for quarter ended June 30 2026
2 months agoScrutinizer report along with result of Evoting
2 months agoScrutinizer report along with result of Evoting
2 months agoAmendments to Memorandum Of Association and Articles of Association of the Company
2 months agoAmendments to Memorandum Of Association and Articles of Association of the Company
2 months agoScrutinizer Report and Voting Results
2 months agoScrutinizer Report and Voting Results
2 months agoProceeding of 2nd Extra Ordinary General Meeting of the Company
2 months agoProceeding of 2nd Extra Ordinary General Meeting of the Company
2 months agoTrading window closure
2 months agoTrading window closure
2 months agoAnnual reports
Concalls & investor presentations
No presentations found